IV Therapy questions

Trials are few and small. The only placebo-controlled trial of the Myers' cocktail, in 34 adults with fibromyalgia, found no significant difference from placebo. A 2026 review called IV longevity therapy experimental.[1][2]

Blood levels go higher. At 1.25 g, IV vitamin C peaked at 885 micromol/L against 134.8 by mouth. The kidneys excrete vitamin C above their threshold, and the IV half-life was 7.4 hours.[1][2]

Magnesium, calcium, B vitamins and vitamin C, as described by A.R. Gaby in 2002.[1]

The one placebo-controlled IV trial did not favor it. A 2025 systematic review called IV glutathione contraindicated for skin lightening.[1][2]

No outcome trial of IV NAD+ for anti-aging or wellness was found in a 2026 review of 113 studies.[1]

IV fluid restored blood volume faster, but heat tolerance and later exercise were no better than after drinking.[1][2]

Contaminated compounded glutathione made more than 25 people ill in 4 states in 2026. High-dose vitamin C can damage the kidneys and cause hemolysis in G6PD deficiency.[1][2]

Most are compounded. There are no FDA-approved glutathione products in the US, and the approved IV vitamin C, Ascor, is labeled for scurvy only.[1][2]

An LPN may give IV therapy under an RN or other practitioner's direction after a 30-hour course and supervised practice, with employer approval. The Board of Medicine said in 2009 that a medical assistant may do IV infusion only with a Florida physician present in the office.[1][2][3]

CDC advises asking whether the product used injectable-grade ingredients, who compounded it, and what sterility and endotoxin steps were taken.[1]